Cell Source, Inc. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances
Cell Source, Inc. (CLCS) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances of $40.17 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-06-24.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues · last filed 2024-06-24
- Cell Source, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for the quarter ending 2021-03-31 was $82.35K.
- Cell Source, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for fiscal 2023 was $40.17K, a 76.88% decline from fiscal 2022.
- Cell Source, Inc. fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, issuances for fiscal 2022 was $173.71K.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances 12 month |
|---|---|---|
| 2023-12-31 | $40.17K 10-K · filed 2024-06-24 | |
| 2022-12-31 | $173.71K 10-K · filed 2024-06-24 | |
| 2021-03-31 | $82.35K 10-Q · filed 2021-05-17 |